1. Chronic Neuroinflammation
Persistent microbial presence or latent infections can lead to sustained microglial activation and the production of pro-inflammatory cytokines such as IL-1β and TNF-α. These processes are associated with neuronal dysfunction and synaptic loss, which are key features of Alzheimer's disease.
2. Amyloid-β and Tau Interactions
Certain pathogens have been reported to:
Enhance amyloidogenic processing or interact with amyloid fibrils.
Induce tau hyperphosphorylation and aggregation.
These interactions may expedite the progression of classical AD neuropathology.
3. Disrupted Homeostasis
Infectious agents can disrupt neuronal metabolism, oxidative balance, and cell survival pathways, increasing genetic and age-related vulnerabilities.
Key Microbial Candidates
Although definitive causality is not established, several pathogen classes have been implicated in AD-related changes:
Herpesviruses: HSV-1 and other herpesviruses have been linked to increased amyloid deposition and inflammatory responses in some studies.
Bacterial agents: Oral and systemic bacteria, such as Porphyromonas gingivalis, have been found in AD brain tissue and may influence amyloid and inflammatory pathways.
Fungi: Fungal DNA and antigens have been identified in brain samples from AD patients in certain studies.
Other viruses: Cytomegalovirus (CMV), hepatitis viruses, and HIV have been associated with altered CNS immune states and may affect neurodegenerative processes.
Clinical and Therapeutic Implications
Anti-Infective and Anti-Inflammatory Strategies
The potential of anti-pathogenic therapies (antivirals, antibiotics, antifungals) and targeted immunomodulation to modify disease progression is discussed. These strategies could be used alongside amyloid- or tau-based approaches or within specific clinical subgroups.
Biomarker Development
Improved tools are necessary to detect microbial DNA, RNA, proteins, or inflammatory markers in cerebrospinal fluid (CSF) or blood, to identify which patients might benefit from targeted interventions.
Limitations and Future Research Directions
The infection hypothesis remains associative rather than causal; rigorous longitudinal and interventional studies are needed.
Many detected microbial signals may be secondary phenomena, resulting from rather than causing neurodegeneration.
Integration with genetic risk factors (e.g., APOE status), vascular factors, and immune aging will be crucial for a multifactorial model of AD.
Take-Home Points for Clinicians
Infection-associated mechanisms may interact with main AD pathways, especially chronic neuroinflammation and amyloid/tau proteinopathy.
Pathogen detection and anti-infective therapies are emerging research areas and are not yet established clinical interventions.
A better understanding of microbial contributions could lead to personalized therapeutic strategies and inform early prevention trials.
Conclusion
This review synthesizes evidence linking pathogens to Alzheimer's disease pathology, integrating microbiological, immunological, and neurodegenerative perspectives. It emphasizes the need for continued translational research into infection-related mechanisms, while acknowledging that the field must advance from correlative findings to causal and interventional validation.